Aphria Inc. Logo (CNW Group/AMP German Cannabis Group Inc.)
ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 /CNW/ - AMP German Cannabis Group Inc. (
AMP ) (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc. s (
Aphria ) (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (
CC Pharma ), have entered into a strategic agreement (the
Co-Promotion Agreement ) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.
The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany. In addition, AMP will organize with the support of CC Pharma, information events in Germany to market Aphria branded products to doctors and pharmacists.
Aphria Inc. Logo (CNW Group/AMP German Cannabis Group Inc.)
ERFURT/BERLIN/DENSBORN, Germany, and LEAMINGTON, ON, Canada, Jan. 26, 2021 /CNW/ - AMP German Cannabis Group Inc. (
AMP ) (CSE: XCX), (Frankfurt: C4T) (ISIN: CA00176G1028) and Aphria Inc. s (
Aphria ) (TSX: APHA) (NASDAQ: APHA) wholly-owned German subsidiary, CC Pharma GmbH (
CC Pharma ), have entered into a strategic agreement (the
Co-Promotion Agreement ) covering joint marketing of sales for Aphria brand medical cannabis products for the German market.
The Co-Promotion Agreement is a collaboration contract between AMP and CC Pharma to sell the Aphria medical cannabis brand in Germany. In addition, AMP will organize with the support of CC Pharma, information events in Germany to market Aphria branded products to doctors and pharmacists.